Psychiatry Tomorrow cover image

Adding SPRAVATO® in Your Practice: A Practical Guide

Psychiatry Tomorrow

00:00

Understanding Spravato: A Breakthrough in Depression Treatment

This chapter explores Spravato, the FDA-approved nasal spray formulation of ketamine for treatment-resistant depression, emphasizing its significance in psychiatric care. It covers pharmacological details, dosing, administration, safety protocols, and clinical trial results related to its efficacy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app